Editas Medicine, Inc. $EDIT Presents at 2022 Wells Fargo Healthcare Conference (Transcript)

Editas Medicine, Inc. (EDIT) Presents at 2022 Wells Fargo Healthcare Conference (Transcript) [Editas Medicine, Inc. (EDIT)] Editas Medicine, Inc. (NASDAQ: EDIT ) 2022 Wells Fargo Healthcare Conference September 7, 2022 1:55 PM ET Company Participants Gilmore O’Neill – Chief Executive Officer Mark Shearman – Chief Scientific Officer Conference Call Participants Yanan Zhu – Wells Fargo Securities Yanan Zhu Hi, everyone. Thanks for joining us.

Read the source article at seekingalpha.com
2022-09-08 01:57:00